Neostigmine is used for the symptomatic treatment of myasthenia gravis

Neostigmine Bromide is the bromide salt of neostigmine, It contains a neostigmine and it is a synthetic physostigmine analog. Neostigmine is used for the symptomatic treatment of myasthenia gravis by improving muscle tone. Neostigmine Bromide is a reversible acetylcholinesterase inhibitor and a Parasympathomimetic agent.

Neostigmine is water-soluble, an ionized compound that reversibly inhibits the enzyme acetylcholinesterase.

Neostigmine Bromide product with CAS: 114-80-7 is also known as 3-[[(Dimethylamino)carbonyl]oxy]-N,N,N-trimethylbenzenaminium Bromide. Neostigmine is the medication used to treat myasthenia gravis, Ogilvie syndrome, and urinary retention without the presence of a blockage. It is also used together with atropine to end the effects of neuromuscular blocking medication of the non-depolarizing type.

Simson Pharma Pvt Ltd is the Supplier of NeostigmineProcess impurities, degradation impurities, potential impurities.These impurities are provided with Certificate of Analysis along with the Characterization Data like NMR,Mass,IR & HPLC Purity.